Latest news
Botanix Pharmaceuticals (ASX:BOT) Gains as Sofdra Commercial Rollout Remains the Key Test - KalkineKalkine · Thu, 06 Aug 2026 10:35:00 GMTLumos Diagnostics (ASX:LDX) Secures US$767,800 FebriDx® Order from PHASE Scientific - KalkineKalkine · Tue, 04 Aug 2026 01:12:00 GMTAroa Biosurgery (ASX:ARX) Sharpens Its US Wound-Healing Push With Senior Commercial Hires - KalkineKalkine · Fri, 31 Jul 2026 07:24:00 GMTInteliCare (ASX:ICR) Unlocks Further Growth Opportunity With Expanded Hardi Aged Care Rollout - KalkineKalkine · Tue, 28 Jul 2026 07:00:00 GMTBotanix Pharmaceuticals (ASX:BOT) Ends FY26 With Record Monthly Sofdra Shipments - KalkineKalkine · Mon, 27 Jul 2026 07:00:00 GMT